Biotage’s 2013 Annual Report and Corporate Governance Report are as of today available at: www.biotage.com Contact: Torben Jörgensen, President and CEO Tel: +46 707 49 05 84, torben.jorgensen@biotage.com Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 09.00 on 26 March 2014. About Biotage Biotage offers efficient separation technologies for use within analytical all the way up to industrial scale as well as highly qualitative solutions for analytical chemistry in research and at commercial analytical laboratories. Biotage’s products are used by e.g. governmental authorities, academic institutions, pharma and food industries. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 445 MSEK in 2013. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com
Biotage AB (publ) publishes its 2013 Annual Report and Corporate Governance Report
| Source: Biotage AB
Attachments
